|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
16
|
|
pubmed:dateCreated |
2004-8-25
|
|
pubmed:abstractText |
The aim of the study was to explore the value of analyzing bone marrow (BM) for the presence of isolated tumor cell(s) (ITCs) in disease-free breast cancer patients 3 years after diagnosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5342-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15328170-Biopsy, Needle,
pubmed-meshheading:15328170-Bone Marrow Cells,
pubmed-meshheading:15328170-Breast Neoplasms,
pubmed-meshheading:15328170-Disease-Free Survival,
pubmed-meshheading:15328170-Female,
pubmed-meshheading:15328170-Follow-Up Studies,
pubmed-meshheading:15328170-Humans,
pubmed-meshheading:15328170-Neoplasm Staging,
pubmed-meshheading:15328170-Predictive Value of Tests,
pubmed-meshheading:15328170-Prognosis,
pubmed-meshheading:15328170-Recurrence,
pubmed-meshheading:15328170-Survival Analysis,
pubmed-meshheading:15328170-Time Factors
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome.
|
|
pubmed:affiliation |
Department of Surgery, Ullevål University Hospital, Oslo, Norway.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
